Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 4 2Phase 2/3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Stomach Neoplasms 62Pancreatic Neoplasms 46Liver Neoplasms 38Colonic Neoplasms 37Esophageal Neoplasms 28Rectal Neoplasms 22Neoplasms 13Neoplasm Metastasis 13Gastrointestinal Neoplasms 12Barrett Esophagus 11Recurrence 10Gastrointestinal Stromal Tumors 10Breast Neoplasms 10Bile Duct Neoplasms 10Pain, Postoperative 9Lung Neoplasms 8Cholangiocarcinoma 8Head and Neck Neoplasms 7Malnutrition 6Hepatitis B 6Carcinoma, Non-Small-Cell Lung 6Biliary Tract Neoplasms 6Agnosia 6Adenocarcinoma 6Prostatic Neoplasms 5Postoperative Complications 5Peptic Ulcer 5Pain 5

Interventions

Immunonutrition Diet 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Frailty × Gastrointestinal × Clear all
NCT03642093 2018-09-11

HOPE

Ochsner Health System

Phase 4 Unknown
60 enrolled
Gastrointestinal

Frailty, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT03465202 2018-03-14

Association of Capecitabine Pharmacokinetics and Toxicity With Aging

Newcastle-upon-Tyne Hospitals NHS Trust

Phase 4 Unknown
100 enrolled
BreastGastrointestinal

Frailty, Breast Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡